The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Narcotic (Opioid) Drugs Market Research Report 2025
Synopsis
Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
The global Narcotic (Opioid) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Narcotic (Opioid) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Narcotic (Opioid) Drugs.
Report Scope
The Narcotic (Opioid) Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Narcotic (Opioid) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Narcotic (Opioid) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Segment by Type
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Segment by Application
Pain Relief Application
Anesthesia Application
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Narcotic (Opioid) Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Narcotics, also called opioids, are a necessary and important part of medical care. They include strong prescription pain relievers, such as oxycodone, hydrocodone, fentanyl, and tramadol. The illegal drug heroin is also an opioid. Some opioids are made from the opium plant, and others are synthetic (man-made).
The global Narcotic (Opioid) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Narcotic (Opioid) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Narcotic (Opioid) Drugs.
Report Scope
The Narcotic (Opioid) Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Narcotic (Opioid) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Narcotic (Opioid) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
Johnson & Johnson
Merck
Mylan
Hikma Pharmaceuticals
Sun Pharma
Endo Pharmaceuticals
Allergan
Segment by Type
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
Segment by Application
Pain Relief Application
Anesthesia Application
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Narcotic (Opioid) Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Hydromorphone
1.2.6 Meperidine
1.2.7 Methadone
1.2.8 Others
1.3 Market by Application
1.3.1 Global Narcotic (Opioid) Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pain Relief Application
1.3.3 Anesthesia Application
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Narcotic (Opioid) Drugs Market Perspective (2019-2030)
2.2 Narcotic (Opioid) Drugs Growth Trends by Region
2.2.1 Global Narcotic (Opioid) Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Narcotic (Opioid) Drugs Historic Market Size by Region (2019-2024)
2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Region (2025-2030)
2.3 Narcotic (Opioid) Drugs Market Dynamics
2.3.1 Narcotic (Opioid) Drugs Industry Trends
2.3.2 Narcotic (Opioid) Drugs Market Drivers
2.3.3 Narcotic (Opioid) Drugs Market Challenges
2.3.4 Narcotic (Opioid) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcotic (Opioid) Drugs Players by Revenue
3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2019-2024)
3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Narcotic (Opioid) Drugs Revenue
3.4 Global Narcotic (Opioid) Drugs Market Concentration Ratio
3.4.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2023
3.5 Narcotic (Opioid) Drugs Key Players Head office and Area Served
3.6 Key Players Narcotic (Opioid) Drugs Product Solution and Service
3.7 Date of Enter into Narcotic (Opioid) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcotic (Opioid) Drugs Breakdown Data by Type
4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2019-2024)
4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2025-2030)
5 Narcotic (Opioid) Drugs Breakdown Data by Application
5.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2019-2024)
5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Narcotic (Opioid) Drugs Market Size (2019-2030)
6.2 North America Narcotic (Opioid) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Narcotic (Opioid) Drugs Market Size by Country (2019-2024)
6.4 North America Narcotic (Opioid) Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Narcotic (Opioid) Drugs Market Size (2019-2030)
7.2 Europe Narcotic (Opioid) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Narcotic (Opioid) Drugs Market Size by Country (2019-2024)
7.4 Europe Narcotic (Opioid) Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2019-2030)
8.2 Asia-Pacific Narcotic (Opioid) Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Narcotic (Opioid) Drugs Market Size (2019-2030)
9.2 Latin America Narcotic (Opioid) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Narcotic (Opioid) Drugs Market Size by Country (2019-2024)
9.4 Latin America Narcotic (Opioid) Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2019-2030)
10.2 Middle East & Africa Narcotic (Opioid) Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
11.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Narcotic (Opioid) Drugs Introduction
11.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.2.5 Teva Recent Development
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Detail
11.3.2 Purdue Pharma Business Overview
11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
11.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.3.5 Purdue Pharma Recent Development
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Detail
11.4.2 Mallinckrodt Business Overview
11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
11.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.4.5 Mallinckrodt Recent Development
11.5 Amneal Pharma
11.5.1 Amneal Pharma Company Detail
11.5.2 Amneal Pharma Business Overview
11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
11.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.5.5 Amneal Pharma Recent Development
11.6 Collegium
11.6.1 Collegium Company Detail
11.6.2 Collegium Business Overview
11.6.3 Collegium Narcotic (Opioid) Drugs Introduction
11.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.6.5 Collegium Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
11.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.7.5 Johnson & Johnson Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Narcotic (Opioid) Drugs Introduction
11.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.8.5 Merck Recent Development
11.9 Mylan
11.9.1 Mylan Company Detail
11.9.2 Mylan Business Overview
11.9.3 Mylan Narcotic (Opioid) Drugs Introduction
11.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.9.5 Mylan Recent Development
11.10 Hikma Pharmaceuticals
11.10.1 Hikma Pharmaceuticals Company Detail
11.10.2 Hikma Pharmaceuticals Business Overview
11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.10.5 Hikma Pharmaceuticals Recent Development
11.11 Sun Pharma
11.11.1 Sun Pharma Company Detail
11.11.2 Sun Pharma Business Overview
11.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
11.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.11.5 Sun Pharma Recent Development
11.12 Endo Pharmaceuticals
11.12.1 Endo Pharmaceuticals Company Detail
11.12.2 Endo Pharmaceuticals Business Overview
11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
11.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.12.5 Endo Pharmaceuticals Recent Development
11.13 Allergan
11.13.1 Allergan Company Detail
11.13.2 Allergan Business Overview
11.13.3 Allergan Narcotic (Opioid) Drugs Introduction
11.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2019-2024)
11.13.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Codeine
Table 3. Key Players of Fentanyl
Table 4. Key Players of Hydrocodone
Table 5. Key Players of Hydromorphone
Table 6. Key Players of Meperidine
Table 7. Key Players of Methadone
Table 8. Key Players of Others
Table 9. Global Narcotic (Opioid) Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Narcotic (Opioid) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Narcotic (Opioid) Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Narcotic (Opioid) Drugs Market Share by Region (2019-2024)
Table 13. Global Narcotic (Opioid) Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Narcotic (Opioid) Drugs Market Share by Region (2025-2030)
Table 15. Narcotic (Opioid) Drugs Market Trends
Table 16. Narcotic (Opioid) Drugs Market Drivers
Table 17. Narcotic (Opioid) Drugs Market Challenges
Table 18. Narcotic (Opioid) Drugs Market Restraints
Table 19. Global Narcotic (Opioid) Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Narcotic (Opioid) Drugs Market Share by Players (2019-2024)
Table 21. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2023)
Table 22. Ranking of Global Top Narcotic (Opioid) Drugs Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Narcotic (Opioid) Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Narcotic (Opioid) Drugs Product Solution and Service
Table 26. Date of Enter into Narcotic (Opioid) Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Narcotic (Opioid) Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2019-2024)
Table 30. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2025-2030)
Table 32. Global Narcotic (Opioid) Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2019-2024)
Table 34. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2025-2030)
Table 36. North America Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Narcotic (Opioid) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Narcotic (Opioid) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Narcotic (Opioid) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Narcotic (Opioid) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Narcotic (Opioid) Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Narcotic (Opioid) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Narcotic (Opioid) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Narcotic (Opioid) Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Narcotic (Opioid) Drugs Product
Table 54. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. Teva Company Detail
Table 57. Teva Business Overview
Table 58. Teva Narcotic (Opioid) Drugs Product
Table 59. Teva Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 60. Teva Recent Development
Table 61. Purdue Pharma Company Detail
Table 62. Purdue Pharma Business Overview
Table 63. Purdue Pharma Narcotic (Opioid) Drugs Product
Table 64. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 65. Purdue Pharma Recent Development
Table 66. Mallinckrodt Company Detail
Table 67. Mallinckrodt Business Overview
Table 68. Mallinckrodt Narcotic (Opioid) Drugs Product
Table 69. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 70. Mallinckrodt Recent Development
Table 71. Amneal Pharma Company Detail
Table 72. Amneal Pharma Business Overview
Table 73. Amneal Pharma Narcotic (Opioid) Drugs Product
Table 74. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 75. Amneal Pharma Recent Development
Table 76. Collegium Company Detail
Table 77. Collegium Business Overview
Table 78. Collegium Narcotic (Opioid) Drugs Product
Table 79. Collegium Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 80. Collegium Recent Development
Table 81. Johnson & Johnson Company Detail
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Narcotic (Opioid) Drugs Product
Table 84. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Merck Company Detail
Table 87. Merck Business Overview
Table 88. Merck Narcotic (Opioid) Drugs Product
Table 89. Merck Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 90. Merck Recent Development
Table 91. Mylan Company Detail
Table 92. Mylan Business Overview
Table 93. Mylan Narcotic (Opioid) Drugs Product
Table 94. Mylan Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 95. Mylan Recent Development
Table 96. Hikma Pharmaceuticals Company Detail
Table 97. Hikma Pharmaceuticals Business Overview
Table 98. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 99. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 100. Hikma Pharmaceuticals Recent Development
Table 101. Sun Pharma Company Detail
Table 102. Sun Pharma Business Overview
Table 103. Sun Pharma Narcotic (Opioid) Drugs Product
Table 104. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 105. Sun Pharma Recent Development
Table 106. Endo Pharmaceuticals Company Detail
Table 107. Endo Pharmaceuticals Business Overview
Table 108. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product
Table 109. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 110. Endo Pharmaceuticals Recent Development
Table 111. Allergan Company Detail
Table 112. Allergan Business Overview
Table 113. Allergan Narcotic (Opioid) Drugs Product
Table 114. Allergan Revenue in Narcotic (Opioid) Drugs Business (2019-2024) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcotic (Opioid) Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Narcotic (Opioid) Drugs Market Share by Type: 2023 VS 2030
Figure 3. Codeine Features
Figure 4. Fentanyl Features
Figure 5. Hydrocodone Features
Figure 6. Hydromorphone Features
Figure 7. Meperidine Features
Figure 8. Methadone Features
Figure 9. Others Features
Figure 10. Global Narcotic (Opioid) Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Narcotic (Opioid) Drugs Market Share by Application: 2023 VS 2030
Figure 12. Pain Relief Application Case Studies
Figure 13. Anesthesia Application Case Studies
Figure 14. Narcotic (Opioid) Drugs Report Years Considered
Figure 15. Global Narcotic (Opioid) Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Narcotic (Opioid) Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Narcotic (Opioid) Drugs Market Share by Region: 2023 VS 2030
Figure 18. Global Narcotic (Opioid) Drugs Market Share by Players in 2023
Figure 19. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2023
Figure 21. North America Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Narcotic (Opioid) Drugs Market Share by Country (2019-2030)
Figure 23. United States Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Narcotic (Opioid) Drugs Market Share by Country (2019-2030)
Figure 27. Germany Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Narcotic (Opioid) Drugs Market Share by Region (2019-2030)
Figure 35. China Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Narcotic (Opioid) Drugs Market Share by Country (2019-2030)
Figure 43. Mexico Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Narcotic (Opioid) Drugs Market Share by Country (2019-2030)
Figure 47. Turkey Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Narcotic (Opioid) Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 50. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 51. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 52. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 53. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 54. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 55. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 57. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 58. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 59. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 60. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 61. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
